Fuji Health Changes Name to Fuji Chemical Industries USA, Inc.
PTSM: Pharmaceutical Technology Sourcing and Management
API and drug product manufacturer changes name to align with parent company.
Fuji Health Science announced that as of Sept. 1, 2016, the name of the company has become Fuji Chemical Industries USA, Inc. to align in identity and mission with its parent company Fuji Chemical Industries Co., Ltd.
The company will continue to operate under its current structure; email addresses have changed to "@fujichemicalusa.com" and the website to www.fujichemicalusa.com to reflect the new corporate identity.
The company manufactures pharmaceutical and bulk pharmaceutical products and food additives. It also offers contract manufacturing services that include API manufacturing; functional APIs, such as drug intermediates; and drug products manufacturing. The company also provides excipients and drug delivery systems.
Source: Fuji Chemical Industries
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
